Pfizer/BioNTech dose first US patients with COVID-19 vaccine

Pfizer and its development partner BioNTech have begun dosing the first people in the US with a potential COVID-19 vaccine, as part of their ongoing phase 1/2 clinical trial. 

No takeover approach, says COVID-19 vaccine developer BioNTe...

Germany’s BioNTech has said it has not received any takeover approaches after it began a high-profile coronavirus vaccine trial with Pfizer in Germany, following press reports over the week

Pfizer, BioNTech aim to start German COVID-19 vaccine trial ...

BioNTech shares pop after coronavirus vaccine deal with Pfiz...

As the coronavirus pandemic spreads across the world and the pressure on health system and economies mounts, Pfizer and BioNTech have agreed to jointly develop a vaccine to prevent the infe

BioNTech and Vir's mega-IPOs go ahead, but struggle to meet ...

Two of the largest ever biotech IPOs have gone ahead this week, although both BioNTech and Vir Biotechnology were valued at the low end of their expected ranges.

BioNTech and Vir prepare mega-IPOs after flurry of launches

Two of the largest-ever biotech initial public offerings (IPOs) are scheduled to go ahead in the coming week, after a flurry of smaller stock market launches last week.